MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,678,220 | -33.5% | 291,659 | -3.9% | 0.00% | -50.0% |
| Q2 2023 | $7,032,895 | -1.2% | 303,404 | -1.0% | 0.00% | 0.0% |
| Q1 2023 | $7,116,477 | +102.0% | 306,348 | +26.2% | 0.00% | +100.0% |
| Q4 2022 | $3,522,739 | -48.0% | 242,780 | -31.6% | 0.00% | -50.0% |
| Q3 2022 | $6,773,000 | +4.2% | 354,955 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $6,503,000 | -35.7% | 357,941 | -10.8% | 0.00% | -33.3% |
| Q1 2022 | $10,118,000 | +5.9% | 401,492 | +16.0% | 0.00% | +50.0% |
| Q4 2021 | $9,555,000 | -30.7% | 346,232 | -18.9% | 0.00% | -33.3% |
| Q3 2021 | $13,791,000 | +4.5% | 427,092 | -1.1% | 0.00% | 0.0% |
| Q2 2021 | $13,202,000 | -15.9% | 431,742 | -16.2% | 0.00% | -25.0% |
| Q1 2021 | $15,693,000 | +45.7% | 515,395 | -5.4% | 0.00% | +33.3% |
| Q4 2020 | $10,771,000 | +46.9% | 544,734 | -3.1% | 0.00% | +50.0% |
| Q3 2020 | $7,332,000 | +17.6% | 562,285 | +2.3% | 0.00% | 0.0% |
| Q2 2020 | $6,236,000 | +11.4% | 549,861 | +40.6% | 0.00% | 0.0% |
| Q1 2020 | $5,597,000 | -33.3% | 391,141 | +26.8% | 0.00% | 0.0% |
| Q4 2019 | $8,396,000 | -11.9% | 308,373 | -7.4% | 0.00% | -33.3% |
| Q3 2019 | $9,534,000 | +53.2% | 333,009 | +48.7% | 0.00% | +50.0% |
| Q2 2019 | $6,222,000 | -14.3% | 223,965 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $7,259,000 | +19.3% | 218,662 | +4.5% | 0.00% | 0.0% |
| Q4 2018 | $6,083,000 | -37.7% | 209,255 | -1.4% | 0.00% | -33.3% |
| Q3 2018 | $9,760,000 | -30.6% | 212,179 | -43.6% | 0.00% | -25.0% |
| Q2 2018 | $14,071,000 | +123.7% | 376,515 | +76.8% | 0.00% | +100.0% |
| Q1 2018 | $6,290,000 | -79.8% | 212,902 | -76.5% | 0.00% | -77.8% |
| Q4 2017 | $31,069,000 | +1.7% | 904,595 | +7.1% | 0.01% | 0.0% |
| Q3 2017 | $30,548,000 | +177.5% | 844,339 | +98.2% | 0.01% | +125.0% |
| Q2 2017 | $11,008,000 | +17.8% | 426,004 | -12.4% | 0.00% | +33.3% |
| Q1 2017 | $9,343,000 | +59.0% | 486,580 | +38.0% | 0.00% | +50.0% |
| Q4 2016 | $5,876,000 | +11.4% | 352,481 | +37.6% | 0.00% | 0.0% |
| Q3 2016 | $5,273,000 | +26.2% | 256,189 | +87.5% | 0.00% | 0.0% |
| Q2 2016 | $4,179,000 | +16.9% | 136,602 | +43.1% | 0.00% | +100.0% |
| Q1 2016 | $3,575,000 | -67.2% | 95,483 | -62.2% | 0.00% | -75.0% |
| Q4 2015 | $10,905,000 | -12.1% | 252,672 | -23.7% | 0.00% | -20.0% |
| Q3 2015 | $12,406,000 | +0.4% | 331,003 | -9.0% | 0.01% | 0.0% |
| Q2 2015 | $12,358,000 | -31.2% | 363,572 | -28.4% | 0.01% | +66.7% |
| Q1 2015 | $17,968,000 | +230.1% | 507,562 | +217.6% | 0.00% | +50.0% |
| Q4 2014 | $5,444,000 | -52.9% | 159,809 | -46.7% | 0.00% | -60.0% |
| Q3 2014 | $11,557,000 | -23.3% | 299,641 | -22.6% | 0.01% | -16.7% |
| Q2 2014 | $15,072,000 | +3.3% | 387,257 | -9.3% | 0.01% | 0.0% |
| Q1 2014 | $14,593,000 | +42.4% | 426,746 | -12.6% | 0.01% | +50.0% |
| Q4 2013 | $10,246,000 | +3.2% | 488,337 | +15.6% | 0.00% | -20.0% |
| Q3 2013 | $9,932,000 | -10.5% | 422,614 | +2.3% | 0.01% | -16.7% |
| Q2 2013 | $11,096,000 | – | 412,923 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |